drugset / Trial / NCT01271478

Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients

NCT01271478

Phase 4 Completed 60 enrolled Coordinación de Investigación en Salud, Mexico
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study was to compare the dual use of telmisartan and captopril vs the individual use of such drugs and placebo on the systemic inflammation of patients on hemodialysis (HD).

Timeline

Start
2009-08
Primary completion
2010-12
Completion
2013-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Captopril Small molecule 25 mg Oral
Subject Telmisartan Other / unclassified 40 mg Oral